Komori
ReproCELL (4978) · PolicyFirst stated

Policy-held shares aimed at expanding the iPS cell technology platform through a capital alliance

First written in FY2023. . Latest entry: FY2023.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Strategic shareholdings to expand the R&D platform through capital alliancesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023First statedAnnual report

    「All investment securities held by the company are strategic shareholdings held on a long-term basis to enhance corporate value and expand future research and development through capital alliances. The company does not hold investment securities for dividend income or pure investment purposes aimed at trading.」

    The company has explicitly stated for the first time its policy of holding investment securities long term as strategic shareholdings to expand research and development and enhance corporate value through capital alliances, rather than for dividend income or trading purposes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for ReproCELL yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Policy-held shares aimed at expanding the iPS cell technology platform through a capital alliance | ReproCELL Incorporated (4978) | Komori